FDA NDC Directory · JSON-LD · Markdown

Tygacil

NDC 0008-4990 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTIGECYCLINE
Labeler / ManufacturerWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021821
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTIGECYCLINE (50 mg/5mL)
Marketing started20080615
Package count1

External sources

Source: openFDA. Public-domain (CC0).